审查加拿大卫生部在基于人体生物监测的风险评估方面的进展,以及前进的道路

Devika Poddalgoda1, Kristin Macey1, Natasha Chander1

  • 1Health Canada, 269 Laurier Ave (W), Ottawa, ON K1A 0K9, Canada.

Toxicology letters
|July 11, 2024
PubMed
概括

加拿大卫生部根据加拿大环境保护法 (CEPA) 使用人类生物监测 (HBM) 数据对化学品进行风险评估 (RA). 未来的方法将纳入弱势群体和新的生物标志物,以加强公共卫生风险评估.

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Overview of Biostatistics in Health Sciences01:19

Overview of Biostatistics in Health Sciences

Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
376
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
311